Innoblative Designs, Inc. of Chicago at MEDICA 2017 in Düsseldorf -- MEDICA Trade Fair

Innoblative Designs, Inc.

4660 N. Ravenswood Ave., 60640 Chicago
USA

Telephone +1 631 5251342
info@innoblative.com

This company is co-exhibitor of
Messe Düsseldorf North America

Hall map

MEDICA 2017 hall map (Hall 16): stand E10-8

Fairground map

MEDICA 2017 fairground map: Hall 16

Contact

Tyler Wanke

Phone
+1 920 450 7529

Email
tyler@innoblative.com

Victor Simoes

Phone
+1 631 525 1342

Email
victor@innoblative.com

Our range of products

Product categories

  • 01  Electromedical equipment / Medical Technology
  • 01.08  Surgery and Endoscopy
  • 01.08.03  Electrosurgical devices (HF)

Electrosurgical devices (HF)

Our products

Product category: Electrosurgical devices (HF)

Innoblative Sira™

Innoblative is a medical device company developing innovative advanced energy medical devices. 

Long term clinical trials have demonstrated in hundreds of American and European patients that post-lumpectomy radio-frequency ablation (RFA) safely provides local recurrence control without radiation therapy and reduces the need for reoperation procedures, without sacrificing cosmetic outcome.

Innoblative's Sira™ device is the first single-use disposable RFA system designed specifically to fit the post-lumpectomy surgical site to thermally ablate beyond the margin of surgery. The Sira™ device aims to destroy residual cancer cells in minutes so that patients can avoid radiation exposure and reduce the need for a reoperation.

More Less

About us

Company details

Innoblative is a medical device company developing innovative advanced energy medical devices.

Long term clinical trials have demonstrated in hundreds of American and European patients that post-lumpectomy radio-frequency ablation (RFA) safely provides local recurrence control without radiation therapy and reduces the need for reoperation procedures, without sacrificing cosmetic outcome.

Innoblative's Sira™ device is the first single-use disposable RFA system designed specifically to fit the post-lumpectomy surgical site to thermally ablate beyond the margin of surgery. The Sira™ device aims to destroy residual cancer cells in minutes so that patients can avoid radiation exposure and reduce the need for a reoperation.

More Less